These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3199600)

  • 1. 2-deoxy-D-(14C)-glucose study of the interaction of caerulein and apomorphine.
    Sugaya K; Maimets MO; Kubota K
    Jpn J Pharmacol; 1988 Sep; 48(1):131-6. PubMed ID: 3199600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of ceruletide in the vertical and horizontal locomotor activities of mice.
    Itoh T; Murai S; Masuda Y; Abe E; Ohkubo N; Itsukaichi O; Shoji S
    Pharmacol Biochem Behav; 1992 Oct; 43(2):571-6. PubMed ID: 1438494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional changes in brain 2-14C-deoxyglucose uptake induced by convulsant and non-convulsant doses of lindane.
    Sanfeliu C; Solà C; Camón L; Martínez E; Rodríguez-Farré E
    Neurotoxicology; 1989; 10(4):727-42. PubMed ID: 2483996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of motor depressant effects of caerulein and N-propylnorapomorphine in mice.
    Vasar E; Maimets M; Nurk A; Soosaar A; Allikmets L
    Pharmacol Biochem Behav; 1986 Mar; 24(3):469-78. PubMed ID: 2939465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of 1,5-anhydro-D-glucitol across plasma membranes in rat hepatoma cells.
    Suzuki M; Akanuma H; Akanuma Y
    J Biochem; 1988 Dec; 104(6):956-9. PubMed ID: 3243769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic demonstration of the antagonism of anthramycin and diazepam against cholecystokinin in the mouse brain using the [14C]-2-deoxyglucose method.
    Sugaya K; Kubota K
    Jpn J Pharmacol; 1988 Sep; 48(1):1-6. PubMed ID: 3199597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small doses of apomorphine and chronic administration of d-amphetamine reduce locomotor hyperactivity produced by radiofrequency lesions of dopaminergic A10 neurons area.
    Stinus L; Gaffori O; Simon H; Le Moal M
    Biol Psychiatry; 1977 Dec; 12(6):719-32. PubMed ID: 563741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine alters prey-catching patterns in the common toad: behavioral experiments and (14)C-2-deoxyglucose brain mapping studies.
    Glagow M; Ewert J
    Brain Behav Evol; 1999 Oct; 54(4):223-42. PubMed ID: 10592384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A caerulein-sensitive potentiation of the behavioral effects of apomorphine by dibutyryl-cAMP.
    Ellinwood EH; Rockwell WJ; Wagoner N
    Pharmacol Biochem Behav; 1983 Dec; 19(6):969-71. PubMed ID: 6318229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
    Mitchell IJ; Luquin R; Boyce S; Clarke CE; Robertson RG; Sambrook MA; Crossman AR
    Mov Disord; 1990; 5(1):49-54. PubMed ID: 2296259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of the fetal rat brain.
    Morimoto A; Imai-Matsumura K; Murakami N
    Neurosci Lett; 1990 Mar; 111(1-2):34-8. PubMed ID: 2336190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.
    Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
    Brain Res; 1999 Oct; 843(1-2):171-83. PubMed ID: 10528123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of substantia nigra lesions on forebrain 2-deoxyglucose retention in the rat.
    Sagar SM; Snodgrass SR
    Brain Res; 1980 Mar; 185(2):335-48. PubMed ID: 6101986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of monoamine oxidase inhibition and dopamine uptake blockade on MPTP-induced increase of 2-[3H]deoxyglucose uptake in specific mesencephalic catecholaminergic nuclei.
    Hess A
    Neurosci Lett; 1990 Apr; 112(1):7-13. PubMed ID: 2143566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of melatonin on 2-deoxy-[1-14C]glucose uptake within rat suprachiasmatic nucleus.
    Cassone VM; Roberts MH; Moore RY
    Am J Physiol; 1988 Aug; 255(2 Pt 2):R332-7. PubMed ID: 3407806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
    Zetler G
    Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.